Ophthalmic adverse effects of immune checkpoint inhibitors: the Mayo Clinic experience | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Clinical science

Ophthalmic adverse effects of immune checkpoint inhibitors: the Mayo Clinic experience

Online download statistics by month:

Online download statistics by month: August 2020 to March 2024

	Abstract	Full	Pdf
Aug 2020	1049	394	375
Sep 2020	1581	697	684
Oct 2020	390	19	9
Nov 2020	309	13	16
Dec 2020	244	13	10
Jan 2021	189	18	12
Feb 2021	240	15	11
Mar 2021	275	20	14
Apr 2021	177	7	4
May 2021	153	5	6
Jun 2021	10	7	3
Jul 2021	13	8	7
Aug 2021	37	26	23
Sep 2021	58	46	31
Oct 2021	545	54	24
Nov 2021	287	24	12
Dec 2021	285	27	18
Jan 2022	184	23	19
Feb 2022	175	17	12
Mar 2022	176	17	14
Apr 2022	140	15	11
May 2022	296	24	7
Jun 2022	190	8	4
Jul 2022	227	12	5
Aug 2022	156	19	8
Sep 2022	139	13	4
Oct 2022	186	22	11
Nov 2022	154	15	9
Dec 2022	67	4	3
Jan 2023	91	9	4
Feb 2023	184	15	7
Mar 2023	141	9	8
Apr 2023	151	10	6
May 2023	104	12	10
Jun 2023	121	14	8
Jul 2023	95	13	1
Aug 2023	87	17	6
Sep 2023	99	5	2
Oct 2023	145	24	2
Nov 2023	139	8	3
Dec 2023	131	3	4
Jan 2024	119	9	14
Feb 2024	114	8	5
Mar 2024	125	8	3
Total	9778	1746	1449